Manabu Daikoku

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Minoru Nakamura, Hisayoshi Kondo, Tsuyoshi Mori et al. · Hepatology · 2006 · 361 citations · Full text

Medicine, Hematology, Immunology +13

Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis

Seigo Abiru, Kiyoshi Migita, Yümi Maeda et al. · Liver International · 2005 · 207 citations

Veterinary Medicine, Immunology, Pathobiology +17

Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection—association between TGF-β1 polymorphisms and hepatocellular carcinoma

Kiyoshi Migita, Seiji Miyazoe, Yümi Maeda et al. · Journal of Hepatology · 2004 · 162 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus

Seiji Miyazoe, Keisuke Hamasaki, Keisuke Nakata et al. · The American Journal of Gastroenterology · 2002 · 146 citations

Medicine, Genetics, Molecular Genetics +17

Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis

Minoru Nakamura, Yuki Shimizu‐Yoshida, Yasushi Takii et al. · Journal of Hepatology · 2004 · 129 citations

Medicine, Immunology, Internal Medicine +13